QA: Clearside Biomedical Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001539029_2020_Clearside_Biomedical_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Lifecore Biomedical INC DE', 'shared_tokens': {'biomedical'}}]}

Graph

Absolute values for 0001539029, Clearside Biomedical Inc

  xvar xval
0 AssetsCurrent 25,219,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 541,000
3 remainder_Assets 1,016,000
4 LiabilitiesCurrent 10,903,000
5 LiabilitiesNoncurrent 4,716,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,320,216
9 ResearchAndDevelopmentExpense 10,976,931
10 remainder_Expenses 0
11 remainder_Revenues 12,888,000
12 remainder_NetIncome 126,545
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 26,776,000
1 Liabilities 15,619,000
2 Expenses 31,297,147
3 Revenues 12,888,000
4 StockholdersEquity 11,157,000
5 NetIncome -18,282,602
6 ComprehensiveNetIncome -18,282,602
7 BaseVar 43,353,346
8 EconomicCapitalRatiobeforeLimitedLiability 0.285
9 EconomicCapitalRatio 1.69

Edgar->Model Mapping

Feature Distribution

Change over Time